|
|
|
Insider
Information: |
Eastbourne Capital Management Llc/ca |
Relationship: |
10% Owner |
City: |
San Rafael |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
44,385,290 |
|
Indirect Shares
|
48,092,752 |
|
|
Direct
Value |
$1,041,357,842 |
|
|
Indirect Value
|
$576,011,194 |
|
|
Total
Shares |
92,478,042 |
|
|
Total
Value |
$1,617,369,035 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Cassava Sciences Inc |
SAVA |
10% Owner |
2009-09-29 |
3,230,204 |
2007-12-31 |
10,901,174 |
Premium* |
|
Mabvax Therapeutics Holdings Inc |
MBVX |
10% Owner |
2009-09-30 |
11,850,000 |
2010-05-10 |
1,532,709 |
Premium* |
|
Amylin Pharmaceuticals Inc |
AMLN |
10% Owner |
2009-09-17 |
13,346,120 |
2007-12-31 |
20,220,126 |
Premium* |
|
MGIC Investment Corp |
MTG |
10% Owner |
2009-09-16 |
10,299,755 |
2009-03-11 |
15,438,743 |
Premium* |
|
Sarepta Therapeutics Inc |
SRPT |
10% Owner |
2010-03-04 |
5,659,211 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
|
2008-08-27 |
4 |
S |
$20.07 |
$128,143,018 |
D/D |
(6,026,562) |
17,200,000 |
0 |
- |
|
MTG |
MGIC Investment Corp |
10% Owner |
|
2009-09-16 |
4 |
S |
$8.96 |
$41,278,295 |
D/D |
(4,600,245) |
10,299,755 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
|
2009-09-16 |
4 |
S |
$14.09 |
$34,088,489 |
D/D |
(2,410,639) |
14,789,361 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
|
2008-04-21 |
4 |
B |
$28.52 |
$25,521,703 |
D/D |
894,000 |
22,469,910 |
2.45 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
|
2009-09-17 |
4 |
S |
$13.89 |
$20,124,372 |
D/D |
(1,443,241) |
13,346,120 |
0 |
- |
|
MTG |
MGIC Investment Corp |
10% Owner |
|
2009-09-15 |
4 |
S |
$8.72 |
$19,126,709 |
D/D |
(2,100,000) |
14,900,000 |
0 |
- |
|
MTG |
MGIC Investment Corp |
10% Owner |
|
2009-09-14 |
4 |
S |
$9.10 |
$13,719,925 |
D/D |
(1,500,000) |
17,000,000 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
|
2008-04-30 |
4 |
B |
$27.72 |
$9,886,393 |
D/D |
356,652 |
22,826,562 |
2.45 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
|
2008-04-11 |
4 |
B |
$29.80 |
$8,723,362 |
D/D |
291,300 |
21,330,442 |
2.45 |
- |
|
SAVA |
Cassava Sciences Inc |
10% Owner |
|
2009-09-28 |
4 |
S |
$4.98 |
$7,746,226 |
D/D |
(1,556,842) |
3,232,277 |
0 |
- |
|
SAVA |
Cassava Sciences Inc |
10% Owner |
|
2009-09-25 |
4 |
S |
$4.98 |
$7,552,050 |
D/D |
(1,518,000) |
4,789,119 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
|
2008-05-07 |
4 |
B |
$27.88 |
$6,976,615 |
D/D |
250,000 |
23,076,562 |
2.45 |
- |
|
SAVA |
Cassava Sciences Inc |
10% Owner |
|
2009-08-07 |
4 |
S |
$3.96 |
$6,585,480 |
D/D |
(1,663,000) |
6,307,119 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
|
2008-04-09 |
4 |
B |
$30.05 |
$6,271,435 |
D/D |
208,700 |
21,039,142 |
2.45 |
- |
|
MBVX |
Mabvax Therapeutics Holdi... |
10% Owner |
|
2008-06-23 |
4 |
S |
$1.26 |
$5,368,884 |
D/D |
(4,261,019) |
11,475,000 |
0 |
- |
|
SRPT |
Sarepta Therapeutics Inc |
10% Owner |
|
2010-03-04 |
4 |
S |
$1.24 |
$5,077,361 |
D/D |
(4,094,646) |
5,659,211 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
|
2008-04-03 |
4 |
B |
$30.50 |
$4,738,918 |
D/D |
155,000 |
20,730,442 |
2.45 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
|
2008-06-06 |
4 |
B |
$29.91 |
$4,489,000 |
D/D |
150,000 |
23,226,562 |
2.45 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
|
2008-04-14 |
4 |
B |
$29.37 |
$4,336,235 |
D/D |
147,308 |
21,477,750 |
2.45 |
- |
|
SAVA |
Cassava Sciences Inc |
10% Owner |
|
2009-03-02 |
4 |
S |
$3.40 |
$3,577,507 |
D/D |
(1,000,000) |
10,075,874 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
|
2008-03-28 |
4 |
B |
$28.10 |
$3,342,017 |
D/D |
118,933 |
20,575,442 |
2.45 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
|
2008-03-25 |
4 |
B |
$28.61 |
$2,574,900 |
D/D |
90,000 |
20,415,442 |
2.45 |
- |
|
MTG |
MGIC Investment Corp |
10% Owner |
|
2009-03-12 |
4 |
B |
$0.85 |
$2,551,799 |
D/D |
2,988,158 |
18,500,000 |
2.45 |
- |
|
SAVA |
Cassava Sciences Inc |
10% Owner |
|
2009-04-02 |
4 |
S |
$4.22 |
$2,538,280 |
D/D |
(600,534) |
9,475,340 |
0 |
- |
|
SAVA |
Cassava Sciences Inc |
10% Owner |
|
2009-07-07 |
4 |
S |
$4.54 |
$1,686,436 |
D/D |
(368,000) |
8,060,897 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|